| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Holmes Lake Manor is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bass Lake Pet Hospital is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Capio Partners provides revenue cycle solutions for some of the nation`s leading healthcare providers and hospital systems, converting uncollected receivables into cash. As the healthcare industry moves towards purchasing solutions, Capio Partners offers leadership, knowledge, innovation, and unsurpassed results to help you maximize revenue and minimize risk.
Novasys Health is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.